Anti-KIFBP antibodies are used in the immunodetection of the protein kinesin family binding protein. In humans, the canonical protein has a reported length of 621 amino acid residues and a mass of 71.8 kDa. Its subcellular localization is in the cytoplasm. It is reported to be highly expressed in the heart, brain, ovary, testis, spinal cord and all specific brain regions examined. A member of the KIF-binding protein family, KIFBP is known to be required for organization of axonal microtubules, and axonal outgrowth and maintenance during peripheral and central nervous system development. The KIFBP gene has been associated with the disease, Goldberg-Shprintzen syndrome. Synonyms for this target antigen include KIAA1279, KIF1BP, TTC20, KIF-binding protein, KIF1 binding protein, and KBP. KIFBP gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species.